New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury

Nature Medicine

Volumn 5, Issue 11, 1999, Pages 1264-1269

  Santiago, Fernando S ^a   Lowe, Harry C ^a   Kavurma, Mary M ^a   Chesterman, Colin N ^a   Baker, Andrew ^b   Atkins, David G ^b   Khachigian, Levon M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b JOHNSON AND JOHNSON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ENZYME; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTERY WALL; ARTICLE; CELL DIVISION; CELL MOTION; CONTROLLED STUDY; EARLY RESPONSE GENE; GENE FUNCTION; GENE TARGETING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INDUCTION; RAT; RECEPTOR BINDING; VASCULAR SMOOTH MUSCLE; WOUND HEALING;

ANIMALS; BASE SEQUENCE; BLOOD; CELL DIVISION; CELLS, CULTURED; DNA, SINGLE-STRANDED; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; HYDROLYSIS; IMMEDIATE-EARLY PROTEINS; IMMUNOHISTOCHEMISTRY; MUSCLE, SMOOTH, VASCULAR; RATS; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 0032717640     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/15215     Document Type: Article

References (45)

1. Haseloff, J. & Gerlach, W.A. Simple RNA enzymes with new and highly specific endoribonuclease activities. Nature 334, 585-591 (1988).
2. Saxena, S.K. & Ackerman, E.J. Ribozymes correctly cleave a model substrate and endogenous RNA in vivo. J. Biol. Chem. 265, 17106-17109 (1990).
3. McCall, M.J., Hendry, P. & Jennings, P.A. Minimal sequence requirements for ribozyme activity. Proc. Natl. Acad. Sci. USA 89, 5710-5714 (1992).
4. James, H.A. & Gibson, I. The therapeutic potential of ribozymes. Blood 91, 371-382 (1998).
5. Simayama, T., Nishikawa, F., Nishikawa, S. & Taira, K. Nuclease-resistant chimeric ribozymes containing deoxyribonucleotides and phosphorothioate linkages. Nucleic Acid Res. 21, 2605-2611 (1993).
6. Heidenreich, O. & Eckstein, F. Hammerhead ribozyme-mediated cleavage of the long terminal repeat RNA of human immunodeficiency virus type-1. J. Biol. Chem. 267, 1904-1909 (1992).
7. Santoro, S.W. & Joyce, G.F. A general purpose RNA-cleaving DMA enzyme. Proc. Natl. Acad. Sci. USA 94, 4262-4266 (1997).
8. Kuwabara, T. et al. Comparison of the specificities and catalytic activities of hammerhead ribozymes and DNA enzymes with respect to the cleavage of BCR-ABL chimeric L6 (b2a2) mRNA. Nucleic Acid Res. 25, 3074-3091 (1997).
9. Stary, H.C. et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Atherosclerosis, American Heart Association. Arterioscler. Thromb. Vasc. Biol. 15, 1512-1531 (1995).
10. Holmes, D.R. et al. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. Am. J. Cordiol. 53, 77C-81C (1984).
11. Jackson, C.L. & Schwartz, S.M. Pharmacology of smooth muscle replication. Hypertension 20, 713-736 (1992).
12. Libby, P., Schwartz, S.M., Brogi, E., Tanaka, H. & Clinton, S. A cascade model for restenosis. Circ. Res. 86 (Suppl. III), 47-52 (1995).
13. Schwartz, S.M., deBlois, D. & O'Brien, E.R.M. The intima: soil for atherosclerosis and restenosis. Circ. Res. 77, 445-465 (1995).
14. Khachigian, L.M., Lindner, V., Williams, A.J. & Collins, T. Egr-1-induced endothelial gene expression: a common theme in vascular injury. Science 271, 1427-1431 (1996).
15. Gashler, A.L. et al. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms' tumor suppressor WT1. Proc. Natl. Acad. Sci. USA 89, 10984-10988 (1992).
16. Khachigian, L.M. et al. Egr-1 is activated in endothelial cells exposed to fluid shear stress and interacts with a novel shear-stress response element in the PDGF A-chain promoter. Arterioscl. Thromb. Vasc. Biol. 17, 2280-2286 (1997).
17. Sumpio, B.E. et al. Regulation of PDCF-B by cyclic strain: lack of involvement of the shear-stress responsive element. Arterioscler. Thromb. Vasc. Biol. 18, 349-355 (1998).
18. Delbridge, G.J. & Khachigian, L.M. FGF-1-induced PDGF A-chain gene expression in vascular endothelial cells involves transcriptional activation by Egr-1. Circ. Res. 81, 282-288 (1997).
19. Santiago, F.S., Lowe, H.C., Day, F.L., Chesterman, C.N. & Khachigian, L.M. Egr-1 induction by injury is triggered by release and paracrine activation by fibroblast growth factor-2. Am. J. Pathol 154, 937-944 (1999).
20. Zuker, M. On finding all suboptimal foldings of an RNA molecule. Science 244, 48-52 (1989).
21. Treisman, R. Journey to the surface of the cell: Fos regulation and the SRE. EMBO J. 14, 4905-4913 (1995).
22. Gashler, A. & Sukhatme, V. Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog. Nucleic Acids Res. Mol. Biol. 50, 191-224 (1995).
23. Santoro, S.W. & Joyce, G.F. Mechanism and utility of an RNA-deaving DNA enzyme. Biochemistry 37, 13330-13342 (1998).
24. Hallahan, D.E. et al. c-jun and Egr-1 participate in DNA synthesis and cell survival in response to ionizing radiation exposure. J. Biol. Chem. 270, 30303-30309 (1995).
25. Seifert, R.A., Schwartz, S.M. & Bowen-Pope, D.F. Developmentally regulated production of platelet-derived growth factor-like molecules. Nature 311, 669-671 (1984).
26. Majesky, M.W., Giachelli, C.M., Reidy, M.A. & Schwartz, S.M. Rat carotid neointimal smooth muscle cells reexpress a developmentally regulated mRNA phenotype during repair of arterial injury. Circ. Res. 71, 759-768 (1992).
27. Majesky, M.W., Benditt, E.P. & Schwartz, S.M. Expression and developmental control of platelet-derived growth factor A-chain and B-chain/Sis genes in rat aortic smooth muscle cells. Proc. Natl. Acad. Sci. USA 85, 1524-1528 (1988).
28. Lemire, J.M., Covin, C.W., White, S., Giachelli, C.M. & Schwartz, S.M. Characterization of cloned aortic smooth muscle cells from young rats. Am. J. Pathol. 144, 1068-1081 (1994).
29. Rafty, L.A. & Khachigian, L.M. Zinc finger transcription factors mediate high constitutive PDGF-B expression in smooth muscle cells derived from aortae of newborn rats. J. Biol. Chem. 273, 5758-5764 (1998).
30. Campbell, G.R. & Campbell, J.H. Smooth muscle phenotypic changes in arterial wall homeostasis: implications for the pathogenesis of atherosclerosis. Exp. Mol. Pathol. 42, 139-162 (1985).
31. Pitsch, R.J. et al. Inhibition of smooth muscle cell proliferation and migration in vitro by antisense oligonucleotide to c-myb. J. Vasc. Surg. 23, 783-791 (1996).
32. Clowes, A.W., Reidy, M.A. & Clowes, M.M. Kinetics of cellular proliferation after arterial injury. Lab. Invest. 49, 327-333 (1983).
33. Buck, R.C. Intimal thickening after ligature of arteries. Circ. Res. 9, 418-426 (1961).
34. Kobayashi, H., Dorai, T., Holland, J.F. & Ohnuma, T. Reversal of drug sensitivity in multidrug-resistant tumor cells by an MDR1 (PGY1) ribozyme. Cancer Res. 54, 1271-1275 (1994).
35. Czubayko, F., Schulte, A.M., Berchem, G.J. & Wellstein, A. Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophin. Proc. Natl. Acad. Sci. USA 93, 14753-14758 (1996).
36. Bauer, G. et al. Inhibition of human immunodeficiency virus-1 (HIV-1) replication after transduction of granulocyte colony-stimulating factor-mobilized CD34(+) cells from HIV-infected doners using retroviral vectors containing anti-HIV-1 genes. Blood 89, 2259-2267 (1997).
37. Crooke, S.T. & Bennett, C.F. Progress in antisense oligonucleotide therapeutics. Ann. Rev. Pharmacol. Toxicol. 36, 107-129 (1996).
38. Dean, N.M. & Griffey, R.H. Identification and characterization of second-generation antisense oligonucleotides. Antisense Nucleic Acid Drug Dev. 7, 229-233 (1997).
39. Dryden, S., Pickavance, L., Tidd, D. & Williams, G. The lack of specificity of neuropeptide Y (NPY) antisense oligodeoxynucleotides administered intracerebroventricularly in inhibiting food intake and NPY gene expression in the rat hypothalamus. J. Endocrinol. 157, 169-175 (1998).
40. Sambrook, J., Fritsch, E.F. & Maniatis, T. in Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory Press, Plainview, New York, 1989).
41. Khachigian, L.M., Williams, A.J. & Collins, T. Interplay of Sp1 and Egr-1 in the proximal PDGF-A promoter in cultured vascular endothelial cells. J. Biol. Chem. 270, 27679-27686 (1995).
42. Horodyski, J. & Powell, R.J. Effect of aprotinin on smooth muscle cell proliferation, migration, and extracellular matrix synthesis. J. Surg. Res. 66, 115-118 (1996).
43. Simons, M., Edelman, E. & Rosenberg, R.D. Antisense proliferation cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid injury model. J. Clin. Invest. 93, 2351-2356 (1994).
44. Halasz, P. & Martin, P. A microcomputer-based system for semi-automatic analysis of histological sections. Proc. Royal Microscop. Soc. 19, 312 (1984).
45. Houston, P. et al. Fluid shear stress induction of the tissue factor promoter in vitro and in vivo is mediated by Egr-1. Arterioscler. Thromb. Vasc. Biol. 19, 281-289 (1999).